EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Cumberland Pharmaceuticals Inc. (CPIX) had EBIT Margin of -34.27% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$9.13M |
|
$-3.29M |
|
$1.93M |
|
$7.20M |
|
$12.26M |
|
$-3.13M |
|
$-0.01M |
|
$-3.14M |
|
$-3.14M |
|
$-3.14M |
|
$-3.29M |
|
$-3.29M |
|
$-3.14M |
|
$-3.13M |
|
$-1.85M |
|
14.96M |
|
14.96M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$32.79M |
|
$0.24M |
|
$38.21M |
|
$71.00M |
|
$34.49M |
|
$5.24M |
|
$15.20M |
|
$49.69M |
|
$21.30M |
|
$7.60M |
|
$21.30M |
|
14.98M |
|
| Cash Flow Statement Financials | |
$0.39M |
|
$-0.06M |
|
$-0.76M |
|
$11.44M |
|
$11.01M |
|
$-0.44M |
|
$0.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.95 |
|
-- |
|
-- |
|
0.20 |
|
0.25 |
|
78.82% |
|
-34.27% |
|
|
EBIT Margin |
-34.27% |
-- |
|
-34.36% |
|
-36.03% |
|
$0.39M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.35 |
|
0.64 |
|
140.57 |
|
-15.43% |
|
-43.27% |
|
-4.63% |
|
-12.38% |
|
$1.42 |
|
$0.03 |
|
$0.03 |
|